vs
Side-by-side financial comparison of New Fortress Energy Inc. (NFE) and Royalty Pharma plc (RPRX). Click either name above to swap in a different company.
Royalty Pharma plc is the larger business by last-quarter revenue ($622.0M vs $326.2M, roughly 1.9× New Fortress Energy Inc.). Royalty Pharma plc runs the higher net margin — 34.4% vs -259.7%, a 294.1% gap on every dollar of revenue. On growth, Royalty Pharma plc posted the faster year-over-year revenue change (4.8% vs -7.0%). Over the past eight quarters, Royalty Pharma plc's revenue compounded faster (4.6% CAGR vs -26.8%).
New Fortress Energy Inc. is a global energy infrastructure firm developing, owning and operating LNG import/export terminals, natural gas supply networks and low-carbon projects. It serves utility, industrial and public sector clients across the Americas and Caribbean, delivering affordable, lower-emission energy resources.
Acceleron Pharma, Inc. is an American clinical stage biopharmaceutical company based in Cambridge, Massachusetts with a broad focus on developing medicines that regulate the transforming growth factor beta (TGF-β) superfamily of proteins, which play fundamental roles in the growth and repair of cells and tissues such as red blood cells, muscle, bone, and blood vessels.
NFE vs RPRX — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $326.2M | $622.0M |
| Net Profit | $-847.1M | $214.2M |
| Gross Margin | 35.5% | — |
| Operating Margin | -193.0% | 62.4% |
| Net Margin | -259.7% | 34.4% |
| Revenue YoY | -7.0% | 4.8% |
| Net Profit YoY | -277.4% | 2.9% |
| EPS (diluted) | $-3.03 | $0.49 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $326.2M | $622.0M | ||
| Q3 25 | $240.3M | $609.3M | ||
| Q2 25 | $228.1M | $578.7M | ||
| Q1 25 | $384.9M | $568.2M | ||
| Q4 24 | $350.7M | $593.6M | ||
| Q3 24 | $446.0M | $564.7M | ||
| Q2 24 | $291.2M | $537.3M | ||
| Q1 24 | $609.5M | $568.0M |
| Q4 25 | $-847.1M | $214.2M | ||
| Q3 25 | $-263.0M | $288.2M | ||
| Q2 25 | $-546.5M | $30.2M | ||
| Q1 25 | $-175.4M | $238.3M | ||
| Q4 24 | $-224.4M | $208.2M | ||
| Q3 24 | $9.3M | $544.0M | ||
| Q2 24 | $-88.9M | $102.0M | ||
| Q1 24 | $54.1M | $4.8M |
| Q4 25 | 35.5% | — | ||
| Q3 25 | 18.1% | — | ||
| Q2 25 | 8.4% | — | ||
| Q1 25 | 21.4% | — | ||
| Q4 24 | 17.6% | — | ||
| Q3 24 | 27.1% | — | ||
| Q2 24 | 23.8% | — | ||
| Q1 24 | 62.4% | — |
| Q4 25 | -193.0% | 62.4% | ||
| Q3 25 | -37.4% | 70.1% | ||
| Q2 25 | -170.3% | 36.3% | ||
| Q1 25 | -3.3% | 94.0% | ||
| Q4 24 | 65.0% | 60.9% | ||
| Q3 24 | 17.8% | — | ||
| Q2 24 | 12.3% | 50.2% | ||
| Q1 24 | 30.4% | -13.0% |
| Q4 25 | -259.7% | 34.4% | ||
| Q3 25 | -109.4% | 47.3% | ||
| Q2 25 | -239.6% | 5.2% | ||
| Q1 25 | -45.6% | 41.9% | ||
| Q4 24 | -64.0% | 35.1% | ||
| Q3 24 | 2.1% | 96.3% | ||
| Q2 24 | -30.5% | 19.0% | ||
| Q1 24 | 8.9% | 0.8% |
| Q4 25 | $-3.03 | $0.49 | ||
| Q3 25 | $-0.96 | $0.67 | ||
| Q2 25 | $-1.99 | $0.07 | ||
| Q1 25 | $-0.65 | $0.55 | ||
| Q4 24 | $-1.10 | $0.46 | ||
| Q3 24 | $0.03 | $1.21 | ||
| Q2 24 | $-0.42 | $0.23 | ||
| Q1 24 | $0.23 | $0.01 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $226.5M | $618.7M |
| Total DebtLower is stronger | $8.2B | $9.0B |
| Stockholders' EquityBook value | $182.6M | $9.7B |
| Total Assets | $10.6B | $19.6B |
| Debt / EquityLower = less leverage | 44.78× | 0.92× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $226.5M | $618.7M | ||
| Q3 25 | $145.2M | $938.9M | ||
| Q2 25 | $551.1M | $631.9M | ||
| Q1 25 | $447.9M | $1.1B | ||
| Q4 24 | $492.9M | $929.0M | ||
| Q3 24 | $90.8M | $950.1M | ||
| Q2 24 | $133.0M | $1.8B | ||
| Q1 24 | $143.5M | $843.0M |
| Q4 25 | $8.2B | $9.0B | ||
| Q3 25 | — | $8.9B | ||
| Q2 25 | — | $8.0B | ||
| Q1 25 | — | $7.6B | ||
| Q4 24 | $8.9B | $7.6B | ||
| Q3 24 | — | $7.6B | ||
| Q2 24 | — | $7.6B | ||
| Q1 24 | — | $6.1B |
| Q4 25 | $182.6M | $9.7B | ||
| Q3 25 | $1.1B | $9.6B | ||
| Q2 25 | $1.3B | $9.5B | ||
| Q1 25 | $1.8B | $9.8B | ||
| Q4 24 | $1.9B | $10.3B | ||
| Q3 24 | $1.6B | $10.3B | ||
| Q2 24 | $1.6B | $9.8B | ||
| Q1 24 | $1.7B | $9.9B |
| Q4 25 | $10.6B | $19.6B | ||
| Q3 25 | $12.0B | $19.3B | ||
| Q2 25 | $12.0B | $18.3B | ||
| Q1 25 | $13.1B | $17.6B | ||
| Q4 24 | $12.9B | $18.2B | ||
| Q3 24 | $12.0B | $18.0B | ||
| Q2 24 | $11.4B | $17.7B | ||
| Q1 24 | $10.9B | $16.1B |
| Q4 25 | 44.78× | 0.92× | ||
| Q3 25 | — | 0.93× | ||
| Q2 25 | — | 0.84× | ||
| Q1 25 | — | 0.78× | ||
| Q4 24 | 4.74× | 0.74× | ||
| Q3 24 | — | 0.74× | ||
| Q2 24 | — | 0.78× | ||
| Q1 24 | — | 0.62× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-76.2M | $827.1M |
| Free Cash FlowOCF − Capex | $-134.8M | — |
| FCF MarginFCF / Revenue | -41.3% | — |
| Capex IntensityCapex / Revenue | 18.0% | — |
| Cash ConversionOCF / Net Profit | — | 3.86× |
| TTM Free Cash FlowTrailing 4 quarters | $-1.4B | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-76.2M | $827.1M | ||
| Q3 25 | $-171.0M | $702.6M | ||
| Q2 25 | $-329.0M | $364.0M | ||
| Q1 25 | $-7.2M | $596.1M | ||
| Q4 24 | $445.3M | $742.5M | ||
| Q3 24 | $-20.0M | $703.6M | ||
| Q2 24 | $113.9M | $658.2M | ||
| Q1 24 | $63.0M | $664.6M |
| Q4 25 | $-134.8M | — | ||
| Q3 25 | $-231.6M | — | ||
| Q2 25 | $-726.7M | — | ||
| Q1 25 | $-262.3M | — | ||
| Q4 24 | $-210.3M | — | ||
| Q3 24 | $-367.0M | — | ||
| Q2 24 | $-493.2M | — | ||
| Q1 24 | $-457.9M | — |
| Q4 25 | -41.3% | — | ||
| Q3 25 | -96.4% | — | ||
| Q2 25 | -318.6% | — | ||
| Q1 25 | -68.2% | — | ||
| Q4 24 | -60.0% | — | ||
| Q3 24 | -82.3% | — | ||
| Q2 24 | -169.3% | — | ||
| Q1 24 | -75.1% | — |
| Q4 25 | 18.0% | — | ||
| Q3 25 | 25.2% | — | ||
| Q2 25 | 174.4% | — | ||
| Q1 25 | 66.3% | — | ||
| Q4 24 | 187.0% | — | ||
| Q3 24 | 77.8% | — | ||
| Q2 24 | 208.4% | — | ||
| Q1 24 | 85.5% | — |
| Q4 25 | — | 3.86× | ||
| Q3 25 | — | 2.44× | ||
| Q2 25 | — | 12.06× | ||
| Q1 25 | — | 2.50× | ||
| Q4 24 | — | 3.57× | ||
| Q3 24 | -2.15× | 1.29× | ||
| Q2 24 | — | 6.45× | ||
| Q1 24 | 1.16× | 139.10× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
NFE
Segment breakdown not available.
RPRX
| Financial Royalty Assets | $592.4M | 95% |
| Royalty Income Other | $29.6M | 5% |
